Treadmill training attenuate STZ-induced cognitive dysfunction in type 2 diabetic rats via modulating Grb10/IGF-R signaling

Brain Res Bull. 2022 Apr:181:12-20. doi: 10.1016/j.brainresbull.2022.01.007. Epub 2022 Jan 20.

Abstract

Type 2 diabetes is a major factor contributing to cognitive decline and Alzheimer's disease (AD). Treadmill running is considered to be a critical approach for mice and rats to lower blood sugar and improve learning and memory capacity. The growth factor receptor-bound protein 10 (Grb10) has been proposed to inhibit insulin signaling and defective brain insulin signaling resulted in the cognitive deficits in patients with AD. However, the positive roles of treadmill training on diabetic- related impaired cognitive function and their molecular mechanisms remain unclear. Here, to investigate whether there was neuroprotective effects of treadmill training on impaired cognitive function caused by diabetes, the rats were injected intraperitoneally with streptozotocin at a dose of 30 mg/kg to establish diabetic model (DM). We found that higher Grb10, BACE1 and PHF10 protein levels in the hippocampus of DM rats, lower phosphorylation IGF-1Rβ and IRS-1(ser307). However, 8 weeks treadmill training effectively reduced abnormal Grb10, enhanced postsynaptic density protein PSD-93, PSD-95, SYN expressions of hippocampus, restored PI3K/Akt/ERK and mTOR/AMPK signaling, thus alleviated spatial learning and memory deficit, compared with DM group. Additionally, treadmill training also increased GLUT4 transportation. Overall, our findings suggest that treadmill intervention improved cognitive impairments caused by diabetes disease partly through modulating Grb10/ PI3K/Akt/ERK as well as mTOR/AMPK signaling.

Keywords: Cognition; Grb10; Insulin receptor; Treadmill training.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage
  • Cognitive Dysfunction / chemically induced
  • Cognitive Dysfunction / metabolism
  • Cognitive Dysfunction / therapy*
  • Diabetes Complications / chemically induced
  • Diabetes Complications / metabolism
  • Diabetes Complications / therapy*
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / complications*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Type 2 / chemically induced
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / metabolism
  • Exercise Therapy*
  • GRB10 Adaptor Protein / metabolism*
  • Glucose Transporter Type 4 / drug effects*
  • Physical Conditioning, Animal* / physiology
  • Rats
  • Running* / physiology
  • Streptozocin / administration & dosage

Substances

  • Antibiotics, Antineoplastic
  • Glucose Transporter Type 4
  • Slc2a4 protein, rat
  • GRB10 Adaptor Protein
  • Streptozocin